According to a report of the State Institute for Drug Control, spending on drugs totaled CZK 55.8bn in 2004 in the Czech Republic, up 7% y-o-y, but the increase was the lowest since 2000. The number of packages of drugs supplied to pharmacies and health care facilities fell by more than 5% to 327.4 million units. Spending on non-prescription drugs and preparations not fully covered by insurance makes up about 20% of total spending. Czech producers made up one-third of the market but received only 20% of total spending. The financial share of drugs whose patent protection has expired is about 45%. Zentiva remained the market leader with an estimated market share of 13-15%.